Adrenergics, inhalants

Adrenergics, inhalants has been studied in 1 paper since 2024: 1 observational study in people. The newest paper, Mar 1, 2024: “Effects from medications on functional biomarkers of aging in three longitudinal studies of aging in Sweden”.

Intervention

1 paper studies it1 findingUpdated

“Adrenergics/inhalants (effect size = 0.089) and lipid-modifying agents/plain (effect size = 0.082) were associated with higher values of cognitive function (improvement)”
Effects from medications on functional biomarkers of aging in three longitudinal studies of aging in SwedenAging cell2024doi:10.1111/acel.14132
  • 1 lab in 1 country
  • Funders: Curtin University of Technology and 7 more
  • Humans1

What did studies of Adrenergics, inhalants find?

1

Studies of Adrenergics, inhalants measured 1 outcome; the most studied are cognitive function (1 study).

Cognitive function

upin humans1

1 study
  1. Adrenergics, inhalants improve cognitive function in humans (effect size = 0.089).

    “Adrenergics/inhalants (effect size = 0.089) and lipid-modifying agents/plain (effect size = 0.082) were associated with higher values of cognitive function (improvement)”

    Humans

    Effects from medications on functional biomarkers of aging in three longitudinal studies of aging in Sweden

    Aging cell

Latest